C U R R I C U L U M V I T A E R E S U M E
PERSONAL INFORMATION
Family name, First name: REDON, JOSEP
Researcher unique identifier: ORCID: 0000-0001-8777-6773
Date of birth: 10/16/1950
Nationality: Spain
URL: http://www.uv.es/jredon
Researcher unique identifier: ORCID: 0000-0001-8777-6773
Date of birth: 10/16/1950
Nationality: Spain
URL: http://www.uv.es/jredon
EDUCATION
1985 PhD in Medicine. University of Valencia, Spain
1978 Specialist in Internal Medicine
1974 Graduate in Medicine. University of Valencia
1978 Specialist in Internal Medicine
1974 Graduate in Medicine. University of Valencia
CURRENT POSITIONS
1995 – Director and Head of Institute of Medicine. Hospital Clinico. University of Valencia
1995 – Full Professor of Medicine. School of Medicine. University of Valencia
1995 – Coordinator of the Research Group in Cardiovascular and Renal disease, INCLIVA Research Institute, University of Valencia
1995 – Full Professor of Medicine. School of Medicine. University of Valencia
1995 – Coordinator of the Research Group in Cardiovascular and Renal disease, INCLIVA Research Institute, University of Valencia
PREVIOUS POSITIONS
1995 Director and Head of Internal Medicine. Hospital Clinico, University of Valencia. Spain
2009 – 2017 Scientific Director. INCLIVA Research Institute. ISCIII and University of Valencia
1981 – 1995 Director and Head of Internal Medicine. Hospital of Sagunto. Spain
1978 – 1981 Specialist of Internal Medicine. Hospital La Fe, Valencia. Spain
2009 – 2017 Scientific Director. INCLIVA Research Institute. ISCIII and University of Valencia
1981 – 1995 Director and Head of Internal Medicine. Hospital of Sagunto. Spain
1978 – 1981 Specialist of Internal Medicine. Hospital La Fe, Valencia. Spain
FELLOWSHIPS AND AWARDS
2019 Björn Folkow Award in Research. European Society of Hypertension. Milan. Italy
2016 DOCTOR HONORIS CAUSA by the University of Carol Davila, Bucharest, Rumania.
2005 – 2018 Honorary member of the Hypertension Societies of Portugal (Lisbon 2005), Bulgaria (Sophia 2008), Latin-American (LASH, Caracas 2013); Romania (Bucharest 2014), Spain (Oviedo 2014), Argentina (Buenos Aires, 2014), European (Milan 2016), Central America and Caribbean (Santo Domingo 2018)
2010 Award for Health Excellence from the European Institute of Health and Social Welfare. Madrid. Spain
1991 – 1993 Fellowship in Nephrology and Hypertension. North-Western University, Chicago, IL, USA
2016 DOCTOR HONORIS CAUSA by the University of Carol Davila, Bucharest, Rumania.
2005 – 2018 Honorary member of the Hypertension Societies of Portugal (Lisbon 2005), Bulgaria (Sophia 2008), Latin-American (LASH, Caracas 2013); Romania (Bucharest 2014), Spain (Oviedo 2014), Argentina (Buenos Aires, 2014), European (Milan 2016), Central America and Caribbean (Santo Domingo 2018)
2010 Award for Health Excellence from the European Institute of Health and Social Welfare. Madrid. Spain
1991 – 1993 Fellowship in Nephrology and Hypertension. North-Western University, Chicago, IL, USA
SUPERVISION OF GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS
1995 – Graduate students: 65; Postdoc 18. School of Medicine and INCLIVA Research. University of Valencia. Spain
Mentoring metrics:
- Publications co-authored: 33 scientific articles (Q1) first authored by the mentorees while supervised in my research group and myself as Senior or corresponding authorship.
- Current positions of mentored: 2 Full Professors, 5 Associated Professors; 2 Heads of Department, 4 Head of Unit
- Relevant achievements: 4 with Grants for training in Medical Research with stages abroad, from the ISCIII (minister of Health, Madrid)
Mentoring metrics:
- Publications co-authored: 33 scientific articles (Q1) first authored by the mentorees while supervised in my research group and myself as Senior or corresponding authorship.
- Current positions of mentored: 2 Full Professors, 5 Associated Professors; 2 Heads of Department, 4 Head of Unit
- Relevant achievements: 4 with Grants for training in Medical Research with stages abroad, from the ISCIII (minister of Health, Madrid)
TEACHING ACTIVITIES
2011 – Professor at the Summer School and Master Courses of the European Society of Hypertension, yearly held Asia and The Americas.
2005 – Professor at the Summer School of the European Society of Hypertension, yearly held in Europe, Asia and The Americas.
1995 – Full Professor – Physiopathology and Semiology. School of Medicine. University of Valencia
1993 – 1995 Associate Professor – Physiopathology and Semiology. School of Medicine. University of Valencia
1995 – Director and co-Director of 33 Doctoral Thesis.
2005 – Professor at the Summer School of the European Society of Hypertension, yearly held in Europe, Asia and The Americas.
1995 – Full Professor – Physiopathology and Semiology. School of Medicine. University of Valencia
1993 – 1995 Associate Professor – Physiopathology and Semiology. School of Medicine. University of Valencia
1995 – Director and co-Director of 33 Doctoral Thesis.
ORGANISATION OF SCIENTIFIC MEETINGS OF NATIONAL OR INTERNATIONAL SOCIETIES
2019 BigMedilytics Project. International Meeting. Valencia, Spain (210 participants)
2019 President of Symposium: State of the Art of Cardiovascular Disease in Latin-America. University Cayetano Heredia (Lima) and University of Valencia. Lima (Peru) (789 participants)
2018 Co-President. European Society of Hypertension and Cardiovascular risk. Barcelona, Spain (4800 participants)
2003 President. Spanish Society of Hypertension and Cardiovascular Risk. Valencia. Spain (3500 (participants)
1991 President. Spanish Society of Hypertension and Cardiovascular Risk. Valencia. Spain (1200 participants)
2019 President of Symposium: State of the Art of Cardiovascular Disease in Latin-America. University Cayetano Heredia (Lima) and University of Valencia. Lima (Peru) (789 participants)
2018 Co-President. European Society of Hypertension and Cardiovascular risk. Barcelona, Spain (4800 participants)
2003 President. Spanish Society of Hypertension and Cardiovascular Risk. Valencia. Spain (3500 (participants)
1991 President. Spanish Society of Hypertension and Cardiovascular Risk. Valencia. Spain (1200 participants)
INSTITUTIONAL RESPONSIBILITIES
2016 – Director of the Institute of Medicine in the Hospital Clinico, University of Valencia
2009 – 2017 Scientific Director. INCLIVA Research Institute. ISCIII, Madrid and University of Valencia
2007 – 2010 International Advisory Board of "CRESCENDO"; 21 COE programme Tohoku University, Japan
2007 – 2010 Clinical Advisor of the National Centre for Cardiovascular Research (ISCIII, Madrid)
2005 – 2014 Member of the PhD Committee, Medical School, University of Valencia
2004 – 2010 President of the Quality Board, Hospital Clínico of Valencia
2009 – 2017 Scientific Director. INCLIVA Research Institute. ISCIII, Madrid and University of Valencia
2007 – 2010 International Advisory Board of "CRESCENDO"; 21 COE programme Tohoku University, Japan
2007 – 2010 Clinical Advisor of the National Centre for Cardiovascular Research (ISCIII, Madrid)
2005 – 2014 Member of the PhD Committee, Medical School, University of Valencia
2004 – 2010 President of the Quality Board, Hospital Clínico of Valencia
REVIEWING ACTIVITIES
2019 – Member of the National Agency for Evaluation of Professors, Minister of Education, Culture, Universities and Research. Spanish Government.
2017 – Vice-Chair Board of Management of Journal Hypertension -Milan (Q1)
2016 – Associate Editor Journal of Hypertension - Milan (Q1)
2010 – 2016 Member of Board of Hypertension – AHA - Hagerstown (D1)
2010 Member of Board of Journal of Hypertension - Milan (Q1),
2010 – Member of Board of Blood Pressure Monitoring - Farmington (Q2)
2000 – Member of Commission for Selection of Professors in Universities across Spain
1995 – Reviewer of Cardiovascular and Internal Medicine Scientific Journals: Circulation, Hypertension, Journal of Hypertension, American Journal of Hypertension, American Journal of Medicine, American Journal of Kidney Disease, European Heart Journal, Nephrology Dialysis and Transplantation, Annals of Internal Medicine.
2017 – Vice-Chair Board of Management of Journal Hypertension -Milan (Q1)
2016 – Associate Editor Journal of Hypertension - Milan (Q1)
2010 – 2016 Member of Board of Hypertension – AHA - Hagerstown (D1)
2010 Member of Board of Journal of Hypertension - Milan (Q1),
2010 – Member of Board of Blood Pressure Monitoring - Farmington (Q2)
2000 – Member of Commission for Selection of Professors in Universities across Spain
1995 – Reviewer of Cardiovascular and Internal Medicine Scientific Journals: Circulation, Hypertension, Journal of Hypertension, American Journal of Hypertension, American Journal of Medicine, American Journal of Kidney Disease, European Heart Journal, Nephrology Dialysis and Transplantation, Annals of Internal Medicine.
MEMBERSHIPS OF SCIENTIFIC SOCIETIES
2015 – 2017 Vice-President I2CV. Research Institution of link between University of Valencia and Polytechnic University of Valencia
2011 – 2013 President of European Society of Hypertension
2005 – 2011 Board of European Society of Hypertension
2000 – 2004 President of Spanish Society of Hypertension
1993 – 2000 Board of Spanish Society of Hypertension
2011 – 2013 President of European Society of Hypertension
2005 – 2011 Board of European Society of Hypertension
2000 – 2004 President of Spanish Society of Hypertension
1993 – 2000 Board of Spanish Society of Hypertension
INVITED SPEAKER IN OFFICIAL MEETINGS OF SCIENTIFIC SOCIETIES AND CONFERENCES*
From a total number of 597 international and 179 national, I select some from the last 2 years
2019 Björn Folkow Award Lecture 29 th European Meeting on Hypertension and Cardiovascular Protection. Milan (Italy). Lecture: 29 th European Meeting on Hypertension and Cardiovascular Protection. Milan (Italy).
2018 Lecture: 1st European Society of Hypertension and Chinese Hypertension League. Peking (China).
Lecture: ESC/ESH Guidelines on BP-Lowering Treatment. Munich (Germany).
Lecture: 26th Annual Congress of the Hungarian Society of Hypertension. Budapest (Hungary).
Lecture: International Forum for the evaluation of Cardiovascular Care. Dubai (Emirates)
2019 Björn Folkow Award Lecture 29 th European Meeting on Hypertension and Cardiovascular Protection. Milan (Italy). Lecture: 29 th European Meeting on Hypertension and Cardiovascular Protection. Milan (Italy).
2018 Lecture: 1st European Society of Hypertension and Chinese Hypertension League. Peking (China).
Lecture: ESC/ESH Guidelines on BP-Lowering Treatment. Munich (Germany).
Lecture: 26th Annual Congress of the Hungarian Society of Hypertension. Budapest (Hungary).
Lecture: International Forum for the evaluation of Cardiovascular Care. Dubai (Emirates)
MAJOR COLLABORATIONS
Daniel Batlle. Head of Department of Nephrology. Northwestern University (renal studies). Chicago IL, USA
Richard Cooper. Head of Department of Cardiovascular Epidemiology, Loyola University. (cardiovascular epidemiology). Maywood. IL. USA
Ruben Artero. Head of Laboratory of Translational Genomics. University of Valencia (animal genomics)
Esteban Morcillo. Full Professor Department of Pharmacology and Dean of the University. University of Valencia (drug treatments)
Guiseppe Mancia, Full Professor Department of Cardiology, University Milano-Bicocca (hypertension and cardiovascular risk)
Richard Cooper. Head of Department of Cardiovascular Epidemiology, Loyola University. (cardiovascular epidemiology). Maywood. IL. USA
Ruben Artero. Head of Laboratory of Translational Genomics. University of Valencia (animal genomics)
Esteban Morcillo. Full Professor Department of Pharmacology and Dean of the University. University of Valencia (drug treatments)
Guiseppe Mancia, Full Professor Department of Cardiology, University Milano-Bicocca (hypertension and cardiovascular risk)
Appendix: All on-going grants and submitted grants applications of the PI (Funding ID)
On-going Grants
*Budget to our group
Project Title | Funding source | Budget Amount (€)* | Period | Role of the PI | Relation to current ERC proposal |
BigMedilytics: Big data for medical analytics | H2020 ICT | 1,062,136 | 2018 - 2021 | Partner [Leader of WP 2 (Population health and chronic disease, comprised of 5 pilots including two on Kidney disease and Heart failure), and Pilots 1 (Comorbidities) and 10 (Sepsis) | Use of AI applied to genomics data to identify biomarkers correlated with medically relevant phenomena |
BODYPASS: API-ecosystem for crosssectorial exchange of 3D personal data | H2020 ICT | 351,937 | 2018 - 2021 | Partner [Leader of Task 5.2 and responsible of deliverables on Data privacy and Data protection impact assessment] | Unrelated |
BigData@Heart: Big Data for Better Hearts | IMI2 | 386,250 | 2017 - 2022 | Partner [Leader of the Tasks 2.4 (development of computational approaches for heart diseases phenotyping and definition), 4.2 (Omic data enrichment and biomarkers identification)] | Big Data (including Omics) advanced analytics for understanding a broad range of heart diseases |
Grant applications
Project Title | Funding source | Budget (€)* | Period | Role of the PI | Relation to current ERC proposal |
ACARE@ME: Advanced care model in multimorbid elderly patients | H2020 - SC1 - BHC | 1,269,375 | 2021 - 2024 | Coordinator of the Project [Leader of 3 WPs, including the Design of the new care model and the Ethics and legal requirements] | Development of new care models for cardiopulmonary and multimorbid patients. |
AIMM: Artificial intelligence for multiMorbidity | H2020 - SC1 - DTH | 493,000 | 2021 - 2023 | Partner [Leads WP5 and acts as Pilot site] | Patients with multimorbidities including cardiac and kidney diseases are the target population |
ARCH: AI for augmenting and automating realtime operational and clinical hospital workflows | H2020 - DT - ICT | 648,000 | 2021 - 2023 | Partner [Leads WP7 and Tasks 1.5 (Security and privacy of data access), 7.1-3] | Unrelated |
DISCLO-SED: Digital diagnostics platform for | H2020 - SC1 - BHC | 313,750 | 2021 - 2025 | Partner | Selection of genetic biomarkers for sepsis risk sepsis early detection |
HYPERNET: Safety and efficacy of a biomarkerguided, first-inclass, curative intervention by drug repurposing in hypertensive patients by network pharmacology | H2020 - SC1 - BHC | 259,372 | 2021 - 2025 | Partner [Member of the Clinical Trial Management Committee] | Trial on a genetic biomarker-guided (Nitric oxide), mechanism-based, and potentially curative intervention in hypertensive patients |
SELF: Smart eHealth hospital of the future | H2020 - DT - ICT | 780,375 | 2021 - 2023 | Partner | Patients with high hospitalization risk due to cardiac and/or kidney chronic diseases are the target population |
WELLBASED: Improving health, wellbeing and equality by evidenced-based urban policies for tackling energy poverty | H2020 - SC1 - BHC | 376,937 | 2021 - 2024 | Partner [Leader of WP7 (Ethics and data protection), Tasks 4.2, 7.1-4, and the implementation of machine learning analyses for health-related data] | Unrelated |
*Budget to our group